BioSpace News Archive

Adaptimmune Therapeutics plc, a leader in cell therapy to treat cancer, announced the pricing of an underwritten public offering of 20,500,000 of its American Depositary Shares at a price to the public of $11.00 per ADS.

Toshiba Corporation (TOKYO: 6502, hereinafter “Toshiba”) and a team led by Professor Yozo Nakazawa at the Department of Pediatrics, Shinshu University, (hereinafter “Shinshu University”), have together developed a “tumor-tropic liposome technology” for gene therapy*

The global hip replacement implants market was valued at approximately US$ 7.0 Bn in 2017.

The global genetic testing services market was valued over US$ 33,500.0 Mn in 2016 and is projected to register a compounded annual growth rate of over 7.6% from 2017 to 2025, according to a new report published by Transparency Market Research titled “Genetic Testing Services Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”.

SYNB1891 is currently being evaluated in a Phase 1 clinical trial in patients with advanced solid tumors or lymphoma

Millions of diabetics around the world rely on insulin pumps for the disease management.

Transparency Market Research has published a new report titled, “Blood Transfusion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”.

Health care associated infections or surgical site infections are the infections acquired among patients during their hospital stay, creating needs for surgical infection control.

An up to date business and commerce study conducted at the headquarters of Transparency Market Research has detected that while the global cardiovascular monitoring and diagnostic devices market is showing great promise for the future, the vendor landscape is already highly competitive.

Transparency Market Research has published a new report titled ‘Bone Grafts and Substitutes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global bone grafts and substitutes market was valued at US$ 2.7 Bn in 2017.